Your browser doesn't support javascript.
loading
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
Evans, Rachael A; McAuley, Hamish; Harrison, Ewen M; Shikotra, Aarti; Singapuri, Amisha; Sereno, Marco; Elneima, Omer; Docherty, Annemarie B; Lone, Nazir I; Leavy, Olivia C; Daines, Luke; Baillie, J Kenneth; Brown, Jeremy S; Chalder, Trudie; De Soyza, Anthony; Diar Bakerly, Nawar; Easom, Nicholas; Geddes, John R; Greening, Neil J; Hart, Nick; Heaney, Liam G; Heller, Simon; Howard, Luke; Hurst, John R; Jacob, Joseph; Jenkins, R Gisli; Jolley, Caroline; Kerr, Steven; Kon, Onn M; Lewis, Keir; Lord, Janet M; McCann, Gerry P; Neubauer, Stefan; Openshaw, Peter J M; Parekh, Dhruv; Pfeffer, Paul; Rahman, Najib M; Raman, Betty; Richardson, Matthew; Rowland, Matthew; Semple, Malcolm G; Shah, Ajay M; Singh, Sally J; Sheikh, Aziz; Thomas, David; Toshner, Mark; Chalmers, James D; Ho, Ling-Pei; Horsley, Alex; Marks, Michael.
Afiliación
  • Evans RA; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • McAuley H; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Harrison EM; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Shikotra A; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Singapuri A; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Sereno M; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Elneima O; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Docherty AB; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Lone NI; Usher Institute, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
  • Leavy OC; Department of Health Sciences, University of Leicester, Leicester, UK.
  • Daines L; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Baillie JK; Roslin Institute, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
  • Brown JS; UCL Respiratory, Department of Medicine, University College London, London, UK.
  • Chalder T; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • De Soyza A; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK; Newcastle upon Tyne Teaching Hospitals Trust, Newcastle upon Tyne, UK.
  • Diar Bakerly N; Manchester Metropolitan University, Manchester, UK; Salford Royal NHS Foundation Trust, Manchester, UK.
  • Easom N; Infection Research Group, Hull University Teaching Hospitals, Hull, UK.
  • Geddes JR; NIHR Oxford Health Biomedical Research Centre, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK.
  • Greening NJ; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Hart N; Lane Fox Respiratory Service, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Heaney LG; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK; Belfast Health & Social Care Trust, Belfast, UK.
  • Heller S; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
  • Howard L; Imperial College Healthcare NHS Trust, London, UK, University College London, London, UK.
  • Hurst JR; UCL Respiratory, Department of Medicine, University College London, London, UK.
  • Jacob J; Centre for Medical Image Computing, University College London, London, UK; Lungs for Living Research Centre, University College London, London, UK.
  • Jenkins RG; National Heart and Lung Institute, Imperial College London, London, UK.
  • Jolley C; Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Kerr S; Roslin Institute, University of Edinburgh, Edinburgh, UK.
  • Kon OM; Imperial College Healthcare NHS Trust, London, UK, University College London, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Lewis K; Hywel Dda University Health Board, Wales, UK; University of Swansea, Swansea, UK; Respiratory Innovation Wales, Llanelli, UK.
  • Lord JM; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • McCann GP; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Neubauer S; NIHR Oxford Health Biomedical Research Centre, University of Oxford, Oxford, UK; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Openshaw PJM; National Heart and Lung Institute, Imperial College London, London, UK.
  • Parekh D; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; Department of Acute Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Pfeffer P; Barts Health NHS Trust, London, UK; Queen Mary University of London, London, UK.
  • Rahman NM; Oxford Respiratory Trials Unit, University of Oxford, Oxford, UK.
  • Raman B; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Richardson M; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Rowland M; Kadoorie Centre for Critical Care Research, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Semple MG; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK; Respiratory Medicine, Alder Hey Children's Hospital, Liverpool, UK.
  • Shah AM; King's College London British Heart Foundation Centre and King's College Hospital NHS Foundation Trust, London, UK.
  • Singh SJ; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Sheikh A; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Thomas D; Immunology and Inflammation, Imperial College London, London, UK.
  • Toshner M; Cambridge NIHR Biomedical Research Centre, Cambridge, UK; NIHR Cambridge Clinical Research Facility, Cambridge, UK.
  • Chalmers JD; University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
  • Ho LP; MRC Human Immunology Unit, University of Oxford, Oxford, UK.
  • Horsley A; Division of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Marks M; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Hospital for Tropical Diseases, University College London Hospital, London, UK.
Lancet Respir Med ; 9(11): 1275-1287, 2021 11.
Article en En | MEDLINE | ID: mdl-34627560
BACKGROUND: The impact of COVID-19 on physical and mental health and employment after hospitalisation with acute disease is not well understood. The aim of this study was to determine the effects of COVID-19-related hospitalisation on health and employment, to identify factors associated with recovery, and to describe recovery phenotypes. METHODS: The Post-hospitalisation COVID-19 study (PHOSP-COVID) is a multicentre, long-term follow-up study of adults (aged ≥18 years) discharged from hospital in the UK with a clinical diagnosis of COVID-19, involving an assessment between 2 and 7 months after discharge, including detailed recording of symptoms, and physiological and biochemical testing. Multivariable logistic regression was done for the primary outcome of patient-perceived recovery, with age, sex, ethnicity, body-mass index, comorbidities, and severity of acute illness as covariates. A post-hoc cluster analysis of outcomes for breathlessness, fatigue, mental health, cognitive impairment, and physical performance was done using the clustering large applications k-medoids approach. The study is registered on the ISRCTN Registry (ISRCTN10980107). FINDINGS: We report findings for 1077 patients discharged from hospital between March 5 and Nov 30, 2020, who underwent assessment at a median of 5·9 months (IQR 4·9-6·5) after discharge. Participants had a mean age of 58 years (SD 13); 384 (36%) were female, 710 (69%) were of white ethnicity, 288 (27%) had received mechanical ventilation, and 540 (50%) had at least two comorbidities. At follow-up, only 239 (29%) of 830 participants felt fully recovered, 158 (20%) of 806 had a new disability (assessed by the Washington Group Short Set on Functioning), and 124 (19%) of 641 experienced a health-related change in occupation. Factors associated with not recovering were female sex, middle age (40-59 years), two or more comorbidities, and more severe acute illness. The magnitude of the persistent health burden was substantial but only weakly associated with the severity of acute illness. Four clusters were identified with different severities of mental and physical health impairment (n=767): very severe (131 patients, 17%), severe (159, 21%), moderate along with cognitive impairment (127, 17%), and mild (350, 46%). Of the outcomes used in the cluster analysis, all were closely related except for cognitive impairment. Three (3%) of 113 patients in the very severe cluster, nine (7%) of 129 in the severe cluster, 36 (36%) of 99 in the moderate cluster, and 114 (43%) of 267 in the mild cluster reported feeling fully recovered. Persistently elevated serum C-reactive protein was positively associated with cluster severity. INTERPRETATION: We identified factors related to not recovering after hospital admission with COVID-19 at 6 months after discharge (eg, female sex, middle age, two or more comorbidities, and more acute severe illness), and four different recovery phenotypes. The severity of physical and mental health impairments were closely related, whereas cognitive health impairments were independent. In clinical care, a proactive approach is needed across the acute severity spectrum, with interdisciplinary working, wide access to COVID-19 holistic clinical services, and the potential to stratify care. FUNDING: UK Research and Innovation and National Institute for Health Research.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Estado de Salud / Salud Mental / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Respir Med Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Estado de Salud / Salud Mental / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Respir Med Año: 2021 Tipo del documento: Article